New electromagnetic brain therapy combined with physical therapy shows 22% improvement in stroke recovery. Preliminary study finds portable treatment reduces disabilityNew electromagnetic brain therapy combined with physical therapy shows 22% improvement in stroke recovery. Preliminary study finds portable treatment reduces disability

Electromagnetic Brain Stimulation Shows Promise in Reducing Stroke Disability

Electromagnetic network-targeted field therapy combined with physical therapy significantly reduced overall disability in stroke survivors compared to those receiving sham stimulation with physical therapy, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2026. The analysis of two small clinical trials found that 33.8% of participants receiving ENTF therapy achieved freedom from disability after three months, compared to just 11.9% in the sham treatment group.

Researchers examined combined data from 124 stroke survivors who were moderately to severely disabled following ischemic stroke. Participants received either ENTF therapy or sham treatment beginning an average of 14 days after their stroke, with all receiving 40 to 45 sessions over 8 to 12 weeks alongside physical therapy. The therapy targets specific brain networks related to motor movement and cognitive functions that become electrically disorganized after stroke.

‘These neural networks show electrical disorganization after a stroke. Stimulating these networks with electromagnetic pulse patterns derived from studies in people who have not had a stroke can model and facilitate the reestablishment of normal network organization,’ said lead study author Jeffrey L. Saver, M.D., FAHA, of UCLA’s David Geffen School of Medicine. The therapy showed no serious adverse effects and participants used portable kits allowing treatment to begin in the hospital and continue at home.

American Stroke Association volunteer expert Joseph P. Broderick, M.D., FAHA, noted the preliminary nature of the findings while acknowledging the strong demand for new recovery methods post-stroke. ‘This study examines two small trials of electromagnetic network-targeted field therapy for stroke patients. The results are preliminary, highlighting the need for larger trials with balanced participant groups to assess the therapy’s effectiveness,’ said Broderick, who was not involved in the study.

The research comes as stroke remains a leading cause of long-term disability in the United States, where it is now the fourth leading cause of death according to the American Heart Association’s Heart Disease and Stroke Statistics 2026 Update available at https://www.heart.org. Motor impairment affecting arm and leg movement is the most common complication after stroke, creating significant challenges for survivors returning to daily activities.

Study participants had an average modified Rankin Scale score of 3.9 at enrollment, indicating moderate to severe disability. Beyond the significant increase in disability-free outcomes, researchers observed measurable improvements across the full range of disability outcomes in the ENTF group. The analysis combined data from the BQ3 and EMAGINE trials conducted between 2021 and 2025, with findings considered preliminary until published in a peer-reviewed journal.

Researchers emphasize that while the results are promising, the main limitation is the analysis of data from two small pilot studies. A single, larger trial is needed to confirm these findings before the therapy could be widely implemented. The abstract is available in the American Stroke Association International Stroke Conference 2026 Online Program Planner at https://professional.heart.org. Additional information about stroke recovery is available through the American Stroke Association at https://www.stroke.org.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Electromagnetic Brain Stimulation Shows Promise in Reducing Stroke Disability.

The post Electromagnetic Brain Stimulation Shows Promise in Reducing Stroke Disability appeared first on citybuzz.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin Withdraws 16,384 ETH to Fund Open-Source Technology and Privacy Projects

Vitalik Buterin Withdraws 16,384 ETH to Fund Open-Source Technology and Privacy Projects

TLDR: Buterin withdrew 16,384 ETH to personally fund open-source projects as Ethereum Foundation reduces spending.  The initiative supports secure hardware, privacy
Share
Blockonomi2026/01/30 16:39
What is the most promising crypto right now? A practical checklist

What is the most promising crypto right now? A practical checklist

Crypto interest often spikes after headlines. This guide helps everyday readers turn curiosity into repeatable checks that limit obvious execution risks. We focus
Share
Coinstats2026/01/30 15:52
Inside Upexi’s SOL play: staking yield and locked token deals

Inside Upexi’s SOL play: staking yield and locked token deals

The post Inside Upexi’s SOL play: staking yield and locked token deals appeared on BitcoinEthereumNews.com. Upexi is the largest public company holding Solana tokens and uses a SOL strategy to build its holdings and generate additional revenue through staking. In an interview with crypto.news, Upexi CEO Allan Marshall explains why the company executed a large equity private placement to build a crypto treasury, citing MicroStrategy’s playbook and a more accommodating U.S. policy backdrop. Summary Upexi is the largest public holder of Solana, using equity raises to build a SOL treasury and earn staking yield. Upexi CEO Allan Marshall spoke with crypto.news in an interview. Corporate strategy focuses on accretive issuances, staking, and discounted locked SOL purchases, not venture investing. Upexi markets itself as a “new institutional gateway to Solana’s (SOL) speed, scale, and rapidly growing ecosystem.” But it isn’t alone, as it joins a handful of rival companies also building Solana treasuries, while dozens of other public entities are focusing on other coins. Speaking to crypto.news, Marshall discusses strategy and market perception. He notes that Upexi is focused on accretive capital raises, staking, and discounted, locked SOL purchases rather than venture investing. He also discusses how the company measures progress through an “adjusted SOL per share” metric designed to remove timing and leverage effects. We also discuss the company’s risk management strategies, which include a buy-and-hold approach, no hedging, disciplined use of leverage, and custody with qualified providers. The entire interview transcript is below: crypto.news: Upexi is now the largest corporate holder of Solana with over 2 million SOL in treasury. Why did you make such a dramatic shift now? Was there something specific that happened in the past few months that gave you the confidence to commit so heavily to a crypto treasury at this time? Allan Marshall: Upexi did the first large-scale equity private placement to create an altcoin treasury, and there were…
Share
BitcoinEthereumNews2025/09/20 02:51